BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8155706)

  • 1. Different effect of 5,6-trans-prostaglandin E2 on plasminogen activation by urokinase and streptokinase.
    Urano T; Ikeda C; Shimokawa M; Kinoshita T
    Biochim Biophys Acta; 1994 Apr; 1205(2):258-61. PubMed ID: 8155706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glu-plasminogen I and II: their activation by urokinase and streptokinase in the presence of fibrin and fibrinogen.
    Takada Y; Makino Y; Takada A
    Thromb Res; 1985 Aug; 39(3):289-96. PubMed ID: 4049320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition by ethanol and acetaldehyde the plasmin activity and plasminogen activation induced by urokinase and streptokinase].
    Roszkowska-Jakimiec W; Jurkowski J; Ostrowska H; Worowski K
    Rocz Akad Med Bialymst (1989); 1988-1989; 33-34():53-66. PubMed ID: 2979011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of activation of prothrombin by streptokinase compared with urokinase and tissue-type plasminogen activator (t-PA).
    Eisenberg PR; Miletich JP; Sobel BE; Jaffe AS
    Thromb Res; 1988 Jun; 50(5):707-17. PubMed ID: 3137687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.
    Cassels R; Fears R; Smith RA
    Biochem J; 1987 Oct; 247(2):395-400. PubMed ID: 3122725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of the activation of Glu-plasminogen by streptokinase and urokinase in the presence of fibrinogen degradation products.
    Takada A; Takada Y
    Thromb Res; 1982 Feb; 25(3):229-35. PubMed ID: 7038978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activation of two isozymes of glu-plasminogen (I and II) by urokinase and streptokinase.
    Takada A; Takada Y
    Thromb Res; 1983 Jun; 30(6):633-42. PubMed ID: 6351345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trans-prostaglandin E2 enhances fibrinolysis.
    Urano T; Shimokawa M; Kinoshita T
    J Pharmacobiodyn; 1992 May; 15(5):261-5. PubMed ID: 1527702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of coagulation on the activation of plasminogen by streptokinase and urokinase.
    Takada A; Urano T; Takada Y
    Thromb Haemost; 1979 Oct; 42(3):901-8. PubMed ID: 505405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine and its thiolactone impair plasmin activity induced by urokinase or streptokinase in vitro.
    Kolodziejczyk-Czepas J; Talar B; Nowak P; Olas B; Wachowicz B
    Int J Biol Macromol; 2012 Apr; 50(3):754-8. PubMed ID: 22197896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of platelets on plasminogen activation by tissue plasminogen activator, urokinase, and streptokinase.
    Gao SW; Morser J; McLean K; Shuman MA
    Thromb Res; 1990 May; 58(4):421-33. PubMed ID: 2112791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombolytics and their use].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the urokinase and streptokinase activation properties of the native and lower molecular weight forms of sheep plasminogen.
    Paoni NF; Castellino FJ
    J Biol Chem; 1979 Mar; 254(6):2064-70. PubMed ID: 154519
    [No Abstract]   [Full Text] [Related]  

  • 14. Control of human plasminogen activation.
    Castellino FJ; Urano T; de Serrano V; Morris JP; Chibber BA
    Haemostasis; 1988; 18 Suppl 1():15-23. PubMed ID: 3127307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses.
    Summaria L; Sandesara J; Yang G; Vagher JP; Caprini JA
    Thromb Haemost; 1986 Aug; 56(1):71-9. PubMed ID: 2946093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zymogen-activation kinetics. Modulatory effects of trans-4-(aminomethyl)cyclohexane-1-carboxylic acid and poly-D-lysine on plasminogen activation.
    Petersen LC; Brender J; Suenson E
    Biochem J; 1985 Jan; 225(1):149-58. PubMed ID: 2579638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activation mechanism of human plasminogen.
    Rickli EE
    Thromb Diath Haemorrh; 1975 Nov; 34(2):386-95. PubMed ID: 128150
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of epsilon-aminocaproyl-S-benzyl-L-cysteine on the activity of plasminogen activators.
    Bruzgo I; Midura-Nowaczek K; KaczyƄska J; Krajewska D
    Acta Pol Pharm; 2009; 66(1):37-40. PubMed ID: 19226966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha 2-plasmin inhibitor deficiency.
    Lipinski B; Gurewich V
    Lancet; 1979 Feb; 1(8111):329. PubMed ID: 84984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.